* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Sample Letter for Prior Authorization Request for BELVIQ ® or
Survey
Document related concepts
Transcript
We cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payer plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims. For additional information, providers should consult with the patient’s payer for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record. If you choose to use this sample letter, please remove or replace all red text, including this box, before sending. Sample Prior Authorization Request Letter Physician’s name Physician’s address Physician NPI Physician’s fax number Physicians’ office contact Patient’s name Patient’s date of birth Patient’s health plan name and ID# Dear Sir or Madam: This is a request for coverage or prior authorization of a weight loss medication for the above named patient that is indicated for adult patients, who are obese (BMI ≥ 30) or overweight (BMI ≥ 27) WITH a weight-related comorbid condition. This request is for [drug, dosage, amount, and duration] Primary Diagnosis E66.01 Morbid (severe) obesity due to excess calories E66.09 Other obesity due to excess calories E66.1 Drug-induced obesity E66.2 Morbid (severe) obesity with alveolar hypoventilation including pickwickian syndrome E66.3 Overweight E66.8 Other obesity E66.9 Obesity, unspecified, NOS Note: E66.3 needs to be accompanied with a diagnosis for a weight-related comorbid condition (below) Secondary Diagnoses Specific BMI (Some health plans may require the inclusion of a more specific BMI designation) Z68.27 Z68.28 Z68.29 Z68.30 Z68.31 Z68.32 Z68.33 Z68.34 Z68.35 BMI 27.0 – 27.9 BMI 28.0 – 28.9 BMI 29.0 – 29.9 BMI 30.0 – 30.9 BMI 31.0 – 31.9 BMI 32.0 – 32.9 BMI 33.0 – 33.9 BMI 34.0 – 34.9 BMI 35.0 – 35.9 Z68.36 Z68.37 Z68.38 Z68.39 Z68.41 Z68.42 Z68.43 Z68.44 Z68.45 BMI 36.0 – 36.9 BMI 37.0 – 37.9 BMI 38.0 – 38.9 BMI 39.0 – 39.9 BMI 40.0 – 44.9 BMI 45.0– 49.9 BMI 50 – 59.9 BMI 60.0 – 69.9 BMI 70 or greater Note: Z68.27, Z68.28, Z68.29 need to be accompanied with a diagnosis for a weight-related comorbid condition (below) Weight-Related Comorbid Condition(s) to Support Use of FDA-Approved Medication for Chronic Weight Management (If applicable, please check any that apply) E11-E11.9 E78.0 E78.1 G47.33 I10 E78.5 I25.1-I25.119 M15-M19 R73.01 ______ Type 2 Diabetes Hypercholesterolemia Hyperglyceridemia Obstructive sleep apnea Hypertension Dyslipidemia/Hyperlipidemia Cardiovascular disease Osteoarthritis Impaired fasting glucose Other Additional Information (If applicable, please check any that apply) S/he has tried and failed to maintain weight loss with the following behavior modification(s): Diet Exercise Other: ______________________________________________________________________ (If applicable, please check any that apply) This drug is medically necessary because without it this patient is at risk for the following adverse consequences: Deterioration of the medical condition with risk of hospitalization, permanent disability, or death Decline in functional ability Progression of a chronic disease or disability Surgical intervention _________________________________ (If applicable, please check any that apply) This request meets the following criteria for medical necessity: The drug will, or is reasonably expected to, reduce or ameliorate the physical, mental, or developmental effects associated with the illness. The drug will assist the patient in achieving or maintaining maximum functional capacity in performing daily activities taking into account both the functional capacity of the individual and those functional capacities that are appropriate for individuals of the same age. (If applicable, please check any that apply) S/he is unable to take the formulary medication/preferred medication because of: There are no prescription weight loss medications on the formulary An adverse reaction A drug-drug interaction A contraindication A failure of a therapeutic trial: [specify which formulary alternatives/preferred medications have been tried and describe results] ___________________________________ Please contact my office should you require any additional information. Sincerely, Signature